Literature DB >> 15744751

Stem cells and pulmonary metamorphosis: new concepts in repair and regeneration.

Jason M Aliotta1, Michael Passero, Joseph Meharg, James Klinger, Mark S Dooner, Jeffrey Pimentel, Peter J Quesenberry.   

Abstract

Adult stem cells are likely to have much more versatile differentiation capabilities than once believed. Numerous studies have appeared over the past decade demonstrating the ability of adult stem cells to differentiate into a variety of cells from non-hematopoietic organs, including the lung. The goal of this review is to provide an overview of the growth factors which are thought to be involved in lung development and disease, describe the cells within the lung that are believed to replace cells that have been injured, review the studies that have demonstrated the transformation of bone marrow-derived stem cells into lung cells, and describe potential clinical applications with respect to human pulmonary disease. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744751     DOI: 10.1002/jcp.20318

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

1.  Long-term research of stem cells in monocrotaline-induced pulmonary arterial hypertension.

Authors:  Yun Luan; Xue Zhang; Tong-Gang Qi; Guang-Hui Cheng; Chao Sun; Feng Kong
Journal:  Clin Exp Med       Date:  2013-08-31       Impact factor: 3.984

Review 2.  The how and why of adult neurogenesis.

Authors:  Inmaculada Ortega-Perez; Kerren Murray; Pierre-Marie Lledo
Journal:  J Mol Histol       Date:  2007-06-29       Impact factor: 2.611

3.  Design and development of tissue engineered lung: Progress and challenges.

Authors:  Joan E Nichols; Jean A Niles; Joaquin Cortiella
Journal:  Organogenesis       Date:  2009-04       Impact factor: 2.500

4.  Resistin-like molecule α stimulates proliferation of mesenchymal stem cells while maintaining their multipotency.

Authors:  Irina A Kolosova; Daniel Angelini; Chunling Fan; John Skinner; Christopher Cheadle; Roger A Johns
Journal:  Stem Cells Dev       Date:  2012-10-05       Impact factor: 3.272

5.  Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension.

Authors:  Olin D Liang; S Alex Mitsialis; Mun Seog Chang; Eleni Vergadi; Changjin Lee; Muhammad Aslam; Angeles Fernandez-Gonzalez; Xianlan Liu; Rajiv Baveja; Stella Kourembanas
Journal:  Stem Cells       Date:  2011-01       Impact factor: 6.277

6.  Enhanced expression of 70-kilodalton heat shock protein limits cell division in a sepsis-induced model of acute respiratory distress syndrome.

Authors:  Zohar Bromberg; Nichelle Raj; Pierre Goloubinoff; Clifford S Deutschman; Yoram G Weiss
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

7.  Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription.

Authors:  Jason M Aliotta; Mandy Pereira; Kevin W Johnson; Nicole de Paz; Mark S Dooner; Napoleon Puente; Carol Ayala; Kate Brilliant; David Berz; David Lee; Bharat Ramratnam; Paul N McMillan; Douglas C Hixson; Djuro Josic; Peter J Quesenberry
Journal:  Exp Hematol       Date:  2010-01-15       Impact factor: 3.084

8.  Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells.

Authors:  Viranuj Sueblinvong; Roberto Loi; Philip L Eisenhauer; Ira M Bernstein; Benjamin T Suratt; Jeffrey L Spees; Daniel J Weiss
Journal:  Am J Respir Crit Care Med       Date:  2007-12-06       Impact factor: 21.405

Review 9.  Cell therapy approaches for lung diseases: current status.

Authors:  Viranuj Sueblinvong; Daniel J Weiss
Journal:  Curr Opin Pharmacol       Date:  2009-04-06       Impact factor: 5.547

10.  Retention of human bone marrow-derived cells in murine lungs following bleomycin-induced lung injury.

Authors:  Janice M Liebler; Carolyn Lutzko; Agnes Banfalvi; Dinithi Senadheera; Neema Aghamohammadi; Edward D Crandall; Zea Borok
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-30       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.